Search
for
Sort by
Research 871–900 of 1000+
- Two Cases of Paradoxical Nonscarring Alopecia after Mesotherapy with Dutasteride
- Cutaneous manifestations of systemic lupus erythematosus
- Severe Infliximab-Induced Alopecia and Scalp Psoriasis in a Woman with Crohn’s Disease: Dramatic Improvement after Drug Discontinuation and Treatment with Adjuvant Systemic and Topical Therapies
- Hair Loss in Autoimmune Cutaneous Bullous Disorders
- Measuring Patient Quality of Life Following Treatment for Alopecia
- Multifocal scalp abscess with subcutaneous fat necrosis and scarring alopecia as a complication of scalp mesotherapy.
- Tumor necrosis factor-induced alopecia: alternative pathology and therapy
- Religious headwear and alopecia: considerations for dermatologists
- Hair and scalp disorders
- Post Herpetic Itch Leading to Frictional Alopecia of Eyebrow and Scalp-A Hitherto Undescribed Phenomenon
- Advances in the extracellular vesicles treatment of alopecia
- AUTOIMMUNE CICATRICIAL ALOPECIA AND THE ROLE OF TRICHOSCOPY IN ITS DIAGNOSIS: A LITERATURE REVIEW
- Pre-/postbiopsy diagnosis concordance in women from an Afro-Caribbean population: Response to Douglas et al “Scalp biopsy influences diagnostic accuracy and treatment in Black women with alopecia: A retrospective study”
- Eosinophils in fibrous tracts and near hair bulbs: A helpful diagnostic feature of alopecia areata
- Evaluation of New Pregnane Derivatives as 5.ALPHA.-Reductase Inhibitor.
- Tumor Necrosis Factor in Sepsis
- Epidemiology, management and the associated burden of mental health illness, atopic and autoimmune conditions, and common infections in alopecia areata: protocol for an observational study series
- Halo naevi, vitiligo and diffuse alopecia areata associated with tocilizumab therapy
- Prevalence of alopecia and its contributing factors among primary healthcare attendees in the Jazan region, Saudi Arabia
- Alopecic Plaques in a Cook
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- Human epithelial hair follicle stem cells and their progeny: Current state of knowledge, the widening gap in translational research and future challenges
- Chemotherapy-induced alopecia
- Dermatologic manifestations of endocrine disorders
- Current and novel methods for assessing efficacy of hair growth promoters in pattern hair loss
- Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation
- The Effect of Plasma Rich in Growth Factors on Pattern Hair Loss: A Pilot Study
- Persistent Sexual Dysfunction and Suicidal Ideation in Young Men Treated with Low-Dose Finasteride: A Pharmacovigilance Study
- The Hair Follicle: A Paradoxical Androgen Target Organ
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)